Cutaquig Approved for Pediatric Patients With Primary Humoral Immunodeficiency

The FDA has approved cutaquig for patients 2 years of age and older with primary humoral immunodeficiency.

Related Keywords

Flemming Nielsen ,Drug Administration ,Octapharma United States President Flemming ,Accessed December ,United States ,